SMARCA4 and neoplasm: In contrast to this tumor suppressor role, gain-of-function of ARID1A and SMARCA4 was found in hepatocellular carcinoma and in breast cancer, respectively, suggesting that SWI/SNFc alterations could also act as oncogenes [51].